Perrigo Co PLC (PRGO)

55.22 +0.94  +1.73% NYSE May 26, 15:35 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
08/07/2020 08:00 EDT Misc Perrigo Co PLC Second Quarter Earnings Conference Call in 2020
08/07/2020 Earnings Perrigo Co PLC Second Quarter Earnings in 2020 Release
05/28/2020 Dividends Amount: 0.225, Declared Date: May 05 2020, Pay Date: Jun 16 2020
05/06/2020 11:30 IST Misc Perrigo Co PLC Annual General Meeting for 2019
04/30/2020 08:30 EDT Misc Perrigo Co PLC First Quarter Earnings Conference Call for 2020
04/30/2020 Earnings Perrigo Co PLC First Quarter Earnings Result for 2020
02/27/2020 08:30 EST Misc Perrigo Co PLC Fourth Quarter Earnings Conference Call for 2019
02/27/2020 Earnings Perrigo Co PLC Fourth Quarter Earnings Results for 2019
02/27/2020 Misc Perrigo Co PLC Annual Report for 2019
02/27/2020 Dividends Amount: 0.225, Declared Date: Feb 18 2020, Pay Date: Mar 17 2020
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.perrigo.com
  • Investor Relations URL: http://perrigo.investorroom.com/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Aug. 07, 2020
  • Last Earnings Release: Apr. 30, 2020
  • Next Ex-Dividend Date: May. 28, 2020
  • Last Ex-Dividend Date: Feb. 27, 2020
  • Description: Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to over the counter and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.

Top Fund Holders

Symbol Name Weighting
XPH SPDR® S&P Pharmaceuticals ETF 4.70%
SSHVX Sound Shore Institutional 4.26%
FTXH First Trust Nasdaq Pharmaceuticals ETF 4.00%
IHE iShares US Pharmaceuticals ETF 3.77%
TMCJX Touchstone Mid Cap C 3.59%
PJP Invesco Dynamic Pharmaceuticals ETF 2.71%
PPH VanEck Vectors Pharmaceutical ETF 2.69%
RRMVX T. Rowe Price Mid-Cap Value R 2.60%
DHFCX Diamond Hill Long-Short C 2.11%
RYH Invesco S&P 500® Equal Wt Hlth Care ETF 1.69%
VASVX Vanguard Selected Value Inv 1.15%
DFTVX DFA US Targeted Value R1 0.66%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.